Valvular Heart Disease: a Regurgitation of the Latest Antithrombotic Recommendations
This conference is being held virtually.
Target Audience
This course is intended for pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
- Review the current guideline recommendations for antithrombotic therapy in patients with valvular heart disease
- Compare and contrast recent trials on antithrombotic therapy and pharmacological options
- Develop a treatment regimen using the appropriate antithrombic regimen for a patient with valvular heart disease
Faculty
Moataz Ali, PharmD, MBA - PGY1 Pharmacy Resident – Aurora Health Care Metro, Inc.
Disclosure
The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose.
1 contact hour of continuing pharmacy education (0.1 CEU) is available for pharmacist participants.
Available Credit
- 1.00 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Price
Click “Take Course” to register for this program.
This conference is being held virtually. A link to the meeting will be provided prior to the event.
Contact the AAH Pharmacy Continuing Education team at AAH-PharmacyCPEsubmission@aah.org if you have any questions or need assistance.